(2S)-1-[(Benzyloxy)carbonyl]-5-oxopiperidine-2-carboxylic acid

Catalog No.: 
ACVDQT678
CAS No.: 
117836-14-3
Molecular Formula: 
C14H15NO5
Molecular Weight: 
277.28
(2S)-1-[(Benzyloxy)carbonyl]-5-oxopiperidine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$544.00InquiryInquiry
1g98%$1360.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S)-1-[(Benzyloxy)carbonyl]-5-oxopiperidine-2-carboxylic acid
IUPAC Name(S)-1-((benzyloxy)carbonyl)-5-oxopiperidine-2-carboxylic acid
Molecular FormulaC14H15NO5
Molecular Weight277.28
SMILESO=C([C@H](CC1)N(C(OCC2=CC=CC=C2)=O)CC1=O)O
InChI KeyIBZDRDHRFDYPTQ-LBPRGKRZSA-N
Synonym(2S)-5-Oxo-1,2-piperidinedicarboxylic acid 1-benzyl ester;(S)-1-((benzyloxy)carbonyl)-5-oxopiperidine-2-carboxylic acid;1,2-Piperidinedicarboxylic acid, 5-oxo-, 1-(phenylmethyl) ester, (2S)-
CAS No.117836-14-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVDQT678 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXQL428 route compound structure diagram
    ACKXQL428117836-13-2In Stock
  2. Then
  3. ACVDQT678 route product structure diagram
    ACVDQT678117836-14-3
Inquiry

2. ACVDQT678 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVDQT678 route product structure diagram
    ACVDQT678117836-14-3
Inquiry

3. ACVDQT678 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVDQT678 route product structure diagram
    ACVDQT678117836-14-3
Inquiry

Comments (0)